De Gregorio, Ennio
Rappuoli, Rino
Article History
First Online: 13 June 2014
Competing interests
: Ennio De Gregorio and Rino Rappuoli are full-time employees and shareholders of Novartis Vaccines. The following products are commercialized by Novartis or are in the pipeline of Novartis Vaccines: MF59 adjuvant; TLR7-based adjuvants; vaccines against <i>Haemophilus influenzae</i>, meningococcus serogroups B, C and ACYW, influenza virus, pertussis, respiratory syncytial virus, and group A and group B streptococcus; and RNA vaccines based on self-amplifying mRNA (SAM).
Free to read: This content has been made available to all.